Live Breaking News & Updates on Prnewswire Viatris
Stay updated with breaking news from Prnewswire viatris. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Share this article Share this article PITTSBURGH, March 4, 2021 /PRNewswire/ Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at the Barclays Global Healthcare Conference on Wednesday March 10, 2021. CEO Michael Goettler, President Rajiv Malik and Chief Financial Officer Sanjeev Narula will answer questions about the company at 3:00 p.m. ET. Interested parties can access a live webcast of the event at investor.viatris.com. An archived version also will be available following the live event and can be accessed at the same location for a limited time. About Viatris Viatris Inc. (NASDAQ: VTRS) is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of- ....
synergies and other one-time cash costs. Viatris CEO Michael Goettler said, The strategic rationale for creating Viatris is as compelling today as when we announced the transaction to create this new company in July 2019. We launched Viatris with a TSR-focused operating model and a commitment to maintaining a strong balance sheet. As we previously stated, our company s priorities in the first three years as we stand up Viatris will be predominately focused on rebalancing the business, generating strong and growing free cash flows, and rapidly de-leveraging. We are confident that our financial guidance for 2021 is the right starting point for Viatris and continue to expect 2021 to be our trough year in terms of revenue, adjusted EBITDA and free cash flow, reflecting a balanced view of both near-term tailwinds and headwinds, particularly given the delay in closing of the combination between Mylan and Pfizer s Upjohn business, Goettler said. ....